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h i g h l i g h t s
 Diagnosis of breast cancer at increasingly earlier stages has encouraged the development 
 
of more conservative mastectomy.
 Breast reconstruc tion is an integral 
 
part of the management of breast cancer providing both psychosocial and aesthetic bene ts.ﬁ
 Tissue expander/implant-based reconstruc tion constitutes 
 
almost 65% of all breast reconstructions.
 Tissue expander/implant-based reconstruc tion can be performed as a two-stage procedure 
 
either in immediate setti ng or delayed.
 Most stud ies on breast reconstructions are 
 
single-center observations and no evide nce-ba sed guidelines are available yet.
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a b s t r a c t
Objective: In this work, t he authors review recent data on the different meth ods and techniques of TE/
implant-based reconstruction to determine the complication pro les and the advantages and disad-ﬁ
vantages of the 
 
different techniques. This informat ion will be 
 
valuable for surgeons perf orming breast
reconstructions.
Materials and methods: A 
 
thorough literature review was conducted by the authors concerning the
current strategy of tissue expander (TE)/implant-based breast 
 
reconstruction following breast cancer
surgery.
Results: Loss of the breast can strongly affect a woman's personal and social life wh ile breast recon-
struction reduces the sense of mutilation felt by women after a mastectomy, and provides psychosocial
as well as aesth etic bene ts. TE/implant-based reconstruction is the most common breast reconstructiveﬁ
strategy, constituting almost 65% of all breast reconstruc tions in the US. Althoug h numerous studies have
been published on various as pects of alloplastic breast reconstructions, most studies are single -center
observations. No evidence-b ased gui delines are available as yet. Conventional TE/im plant-based recon-
struction can be perform ed as a two-stage procedure eit her 
 
in the immediate or delayed setting.
Moreover, the adjunctive use of acellular derm al matrix further broadened the all oplastic breast
reconstruction indication and also enhanced aesthetic outc omes.
Conclusions: TE/implant- based reconstruction 
 
has proved to be a safe , cost-effective, and reliable tech-
nique tha t can be 
 
performed in women with various comorbidities. Short operative time, fast recovery,
and absence of donor 
 
site morbidity are other advantages 
 
over autologous 
 
breast reconstruc tion.
© 2017 The Author(s). Published by Elsevier Ltd on behal f of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license ( ).http://c reativecommons.org/licenses/by-nc-nd/4.0/
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1. Introduction
Breast cancer (BC) is by far the most common cancer in 
 
women,
affecting about 12.5% women in the United States . 
 
Its diagnosis[1]
at increasingly earlier stages has encouraged the development of
more conservative 
 
mastectomy procedures, such as nipple-sparing,
skin-sparing, and skin-reducing mastectomies . The loss of a[2 5]e
breast can be a traumatic 
 
experience, with serious effects on the
quality of life . For women who have undergone a mastectomy,[6,7]
breast reconstruction provides psychosocial as well as aesthetic
bene ts . Breast reconstruction has therefore come to beﬁ [8 13e ]
regarded as not just a cosmetic procedure but an integral part of the
management of BC [14,15] Fig. 1(see ).
Although different approaches for post-mastectomy breast
reconstruction exit, tissue expander (TE)/implant-based recon-
struction constitutes almost 65% of all breast reconstructions in the
US because it is considered a safe, 
 
cost-effective, and 
 
reliable
technique that can be performed in women with a 
 
wide variety of
comorbid states [16 20]e . Even though autologous breast recon-
struction provides 
 
a better 
 
cosmetic outcome and more natural-
appearing breast reconstruction, TE-based reconstructions have
the advantages of shorter operative time, faster recovery, and no
donor 
 
site morbidity [21]. Moreover, autologous breast recon-
struction can still be performed in case TE-based reconstruction
fails.
Conventional 
 
TE/implant-based reconstruction can be per-
formed as a two-stage procedure 
 
either in immediate setting at the
time of the mastectomy or delayed. During the rst step, a completeﬁ
submuscular pocket is created for the 
 
TE by elevating the infero-
lateral portion of the pectoralis major muscle and the anterior
insertion of the anterior serratus muscle. The second step TE-d
implant exchange is performed once the desired breast expansiond
is achieved. A technical modi cation to TE-based breast recon-ﬁ
struction is the use of the acellular dermal matrix (ADM) of either
human or bovine origin, which allows creation 
 
of the submuscular
pocket by mobilization of only the pectoralis major muscle .[22,23]
The use of ADM provides numerous advantages over the conven-
tional technique, but there are also potential disadvantages,
including higher cost . More recently, 
 
autologous dermal grafts[24]
have been proposed as an alternative to ADM .[25,26]
There are numerous works in the literature on the methods,
timing, complications, and safety of TE-based reconstruction, but
most are based on empirical observations from single centers and
do not provide 
 
evidence-based results [27e30]. Our work attempts
to help both surgeons and their patients in the decision-making
stage of breast reconstruction by collating recent data on the
different method and techniques of TE-based breast reconstruction
in order 
 
to determine the complication pro les and improve theﬁ
health care quality.
2. History of TE/implant-based breast 
 
reconstruction
The rst report of tissue expansion dates back to the 1957, whenﬁ
Neumann 
 
demonstrated its feasibility for achieving coverage of a
subauricular defect . However, more than 20 years had to pass[31]
prior that interest in tissue expansion 
 
rose again following the work
of Radovan in the 1978 and Austad in 1982 [32 34]e . The safety and
ef cacy of tissue expansion has since been thoroughly proven, andﬁ
it has gained wide acceptance. 
 
The design of the TE has improved
over time, 
 
and with the port incorporated in the surface of the
implant, there is no longer any need 
 
for creation of a distal pocket
for valve location. Moreover, textured expanders reduced the issue
of their migration from the area of higher skin tightness (e.g., the
inferior quadrants 
 
of the skin envelope) ensuring a better de nitionﬁ
of the inframmamary 
 
line. Like breast implants, TEs are available in
different shapes, including round and contoured shapes, which
allow for greater lower pole expansion, thus increasing the 
 
upper
pole slope.
The history of breast implants is even older than that of TEs and
starts in the 19th century 
 
when a lipoma of the back was grafted
into the breast in an attempt to provide breast augmentation .[35]
Since then, 
 
different materials have been investigated, but it was
only in the early 
 
1960s that silicone implants, as 
 
currently designed,
started being widely adopted . The early generations of silicon[36]
implants experimented with varying thicknesses of the outer sili-
con layer and with silicon gel of different densities in the attempt to
reduce the occurrence 
 
of capsule contracture, uid migration, andﬂ
ruptures . Modern silicon implants are made of a three-[36]
dimensional 
 
matrix of cross-linked silicone 
 
molecules that do 
 
not
leak out even in case of rupture of the outer layer . Moreover,[36]
the introduction of textured implants has reduced capsular
contracture rates and the possibility of implant malposition .[36]
The latest generation of silicon implants display a vast range of
shapes and volumes, varying implant width, height, and projection
on the chest wall. Some manufactures provide silicon implants
characterized by a more cohesive silicon gel on the top to ensure
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over-projection, and a softer gel in the remaining portion to provide
a more natural feeling when touched.
3. General considerations
TE/implant-based reconstruction aims to achieve a highly pro-
jected, medium-sized breast (40 0 50 0 cc), with little 
 
to moderatee
ptosis, rather than to create an exact match of the contralateral
breast contour [37]. Therefore, patients undergoing unilateral
reconstruction must be aware 
 
that they may eventually need to
undergo contralateral breast augmentation, 
 
reduction, or masto-
pexy for breast symmetrization .[38]
Small-to medium-sized breasts can be reconstructed with im-
plants of the proper size and shape. Indeed, extra-projected,
anatomically-shaped prostheses lled with highly cohesive siliconﬁ
gel can ensure outstanding 
 
cosmetic outcome as well as a safe
surgical procedure, and thus help the patient avoid autologous
breast reconstruction with its associated 
 
donor site morbidity
[39,40]. Even a large-breasted patient can be made eligible for
implant-based, one-step reconstruction by means of skin 
 
reducing
mastectomy . However, autologous breast reconstruction is[2]
indicated in 
 
the patient with large ptotic breasts, who is willing to
maintain a large-sized breast and refuses contralateral surgery.
Both stages of TE/implant-based reconstruction can be per-
formed as a one-day surgery procedure; the entire procedure takes
only 11 /2 h, causes minimal morbidity and, unlike autologous breast
reconstruction, leaves no 
 
donor site scar . However, complica-[36]
tions related to implant use, as well as contour deformities, are
possibilities that must be taken into the 
 
reckoning. In addition, an
adequate skin envelope is needed to support the expansion process,
and hence history of 
 
smoking, scleroderma, or radiotherapy is
relative contraindications .[36]
Thus, almost every patient is eligible for immediate or delayed
(from the 3rd postoperative month) 
 
TE/implant-based recon-
struction . For the previously irradiated breast, however, other[36] 
reconstructive strategies are 
 
advisable, given the unacceptable rate
of severe complications (e.g., implant extrusion, capsular contrac-
ture, or implant displacement) in this 
 
setting [41e46]. The same
consideration is due for patients undergoing radiotherapy 
 
prior to
TE/implant exchange. 
 
When post-mastectomy radiation is planned,
the patient should be discouraged from undergoing immediate TE-
breast reconstruction and be informed of the high risk of implant
extrusion, which may require switch to autologous breast
reconstruction.
Radiation therapy may be administered since prior to mastec-
tomy till the completion of tissue expansion. Patients with up to T2-
stage BC may not require radiotherapy af ter mastectomy [47];
however, given the increasing prevalence of BC and the growing
indications for adjuvant radiotherapy, the number of 
 
patients who
are willing to undergo TE-breast reconstruction, and at the same
time are eligible for radiotherapy, keep rising .[48]
Adjuvant radiation therapy improves the outcomes of patients
whose risk of BC locoregional recurrence exceeds 
 
25% 30%e
[49 51e ]. There is 
 
unanimous agreement that radiotherapy is indi-
cated in patients with at least four positive axillary nodes and/or
locally 
 
advanced disease (T3, T4, or skin involvement) .[52 54]e
However, the need for radiation is 
 
determined only after pathologic
analysis of lymph nodes and tumor margins. Thus, when the need
for radiation therapy seems likely, but it is not required in the
preoperative setting, a delayed-immediate strategy may 
 
be advis-
able . In this 
 
approach, a partially in ated TE is placed at the[55 58]e ﬂ
time of mastectomy, so that the initial shape and thickness of the
breast skin aps is preserved for 3 4 
 
days, till the pathologic an-ﬂ e
alyses are completed. If pathologic analysis shows that adjuvant
radiation therapy is not needed, conventional tissue expansion can
be performed, with outcomes similar to 
 
those obtainable with
immediate breast reconstruction. On the other hand, if the patient
requires postmastectomy radiation therapy, the TE will have to be
completely de ated, to leave a at chest wall surface that willﬂ ﬂ
permit modern, three-beam radiation delivery. Once radiation
therapy is completed, skin-preserving 
 
delayed reconstruction can
be performed. Alternatively, patients may undergo tissue expan-
sion during postoperative chemotherapy and receive radiation
therapy only after TE/implant exchange . This approach[36]
broadens the eligibility for TE-based reconstruction to also include
women requiring adjuvant radiotherapy. Complications and
extrusion rates are lower than in patients who undergo radiation
with the TE in situ. The capsular contracture rate is still high, but
the satisfaction rate is not signi cantly 
 
different from that of pa-ﬁ
tients who have not 
 
received radiation .[59] 
Nevertheless, the best reconstructive strategy 
 
in patients, who
will receive or have already received radiation therapy, is delayed
autologous tissue reconstruction after adjuvant radiation therapy
has been completed [60] .
4. Preoperative planning
The preoperative project should be made the day before the
operation by the oncologic surgeon together with the plastic sur-
geon. BC localization, BC dimensions, and nipple-areola involve-
ment have to be evaluated cautiously. Preoperative markings
should favorably locate the mastectomy scar, while preserving the
required skin envelope. The inframammary fold (IMF) and the
borders 
 
of the breast, must be marked with the patient 
 
in a
standing position. The upper pole border should match the level of
the contralateral one, which can be delineated by gently com-
pressing the contralateral breast against the chest wall. 
 
Nipple-to-
sternal notch distance, 
 
areola-to-IMF distance, and breast width are
measured at this stage. Skin quality, elasticity, and thickness are
also assessed. When matching surgery on the contralateral breast is
to be performed at the same time as the 
 
mastectomy, the preop-
erative markings on the contralateral breast are also drawn; breast
augmentation, breast reduction, and mastopexy are the 
 
usual
procedures required.
Fig. 1. Preoperative pictures (a, b) of a 46-year old patient prior to skin-preserving mastectomy and sentinel lymph node biopsy. (c) Intraoperatively, the expander can be seen
within the submuscular pocket. The big arrow indicates the pectoralis major muscle, while the small one indicates the anterior serratus muscle. The nal result af ter TE/implantﬁ
exchange 
 
and secondary 
 
procedures (nipple-areola complex reconstruction and tattooing). (d, e).
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At this stage, the surgeon should already have a clear picture 
 
in
mind of the nal result 
 
of the reconstructed breast, so 
 
that the bestﬁ
TE dimensions and location can be selected most wisely. The base
diameter and volume of the eventually placed implant determines
the choice of the TE, while 
 
the habitus of the patients guides the
selection of the contour pro le of the TE. The choice of the TE is alsoﬁ
in uenced by the surgeon's preferences, the 
 
project for theﬂ
contralateral breast, and the patient's wishes. The surgeon must be
aware that the patient's 
 
main concern 
 
is her attractiveness 
 
af ter the
breast reconstruction and that 
 
the nal breast size interacts withﬁ
body size to in uence the patient's satisfaction with her self-imageﬂ
[61]. However, as a general rule, a TE with base diameter >15 c m
should be avoided even for reconstruction of a large breast as it can
limit the mobility of the homolateral arm. Furthermore, while the
TE height should generally match that of the 
 
contralateral breast,
TEs with too much or too little height are not advisable.
Full-projection TEs help 
 
recruit upper pole tissue to highly
expand the lower pole, giving a naturally ptotic appearance to the
reconstructed breast . To prevent nipple-areola complex 
 
(NAC)[62]
displacement, precise 
 
location of the TE is mandatory when
reconstructing a breast after a nipple-sparing mastectomy.
With the increase 
 
in the 
 
range of reconstructive strategies
available in BC surgery, the complexity of the decision-making
process has increased , and algorithms, ow charts, and[63 65]e ﬂ
nomograms have been proposed by different researchers to aid the
less-experienced surgeon . More recently, surgical[64,66 69]e
planning systems have been devised, as also virtual simulator
systems, to train surgeons outside of the 
 
apprenticeship model
[70 72e ].
5. Surgical technique
The mastectomy prior to TE-breast reconstruction can be either
a simple skin-sparing, skin-reducing, NAC-sparing mastectomy or a
skin-reducing NAC-sparing mastectomy. In the last 20 years, mas-
tectomy incisions have changed; the oblique incision placed in the
medial aspect of the mastectomy as inferiorly as possible has given
way the to the 
 
horizontal incision used during skin sparing mas-
tectomies today. For nipple-sparing mastectomies, a periareolar
incision is performed instead, with or without a small lateral
extension. Indeed, oblique incisions tend to result in a medial dog-
ear and dif cult lower pole expansion . Moreover, compared toﬁ [73]
the older IMF incision, the newer incisions provide better exposure
during mastectomy and also reduce the risk to the blood supply to
the skin aps and the 
 
NAC, while allowing easier TE-implant ex-ﬂ
change and circumferential capsulotomy .[43 77]e
The IMF is a crucial landmark of the breast. It extends from the
bottom of the fth rib medially to the top of the seventh ribﬁ
laterally, and is usually easily preserved during mastectomy .[36]
Gross anatomic and histologic 
 
studies have shown that it is a
specialized part of the super cial fascial system, where organizedﬁ
collagen bers in the dermis and/or an actual ligament arising fromﬁ
periosteum and the intercostal 
 
fascia join the superﬁ cial fascial
layer of the subcutaneous tissue . When disrupted during[78,79]
mastectomy, it must be restored, either immediately or during a
subsequent surgery, using 4 5 braided silk or Vicryle ® sutures .[38]
5.1. First stage
5.1.1. Immediate breast reconstruction
After completing the mastectomy, and before 
 
commencing
reconstruction, the surgeon assesses the blood supply of the skin
ﬂaps. Traditionally, this done on the basis of skin ap color, capillaryﬂ
re ll, temperature, turgor, and dermal bleeding ; however,ﬁ [80]
ﬂuorescein angiography and laser-assisted indocyanine green
angiography are now available as adjunctive diagnostic tools
[81,82]. Some 
 
authors suggest a 
 
second dose of prophylactic anti-
biotics and re-application of the surgical prep in order to reduce the
risk of postoperative infection, even though no de nite evidence ofﬁ
bene t has been demonstrated .ﬁ [38]
If the mastectomy aps are deemed viable, the surgeon canﬂ
proceed with immediate reconstruction by creating the pocket for
the TE. Either 
 
a partial or complete submuscular pocket is created,
with the same dimensions as the selected expander. The chosen TE
should have the same base width and height 
 
as the contralateral
breast. It is important to avoid implant visibility or exposure and so
complete sof t tissue coverage of the TE must be ensured.
Some authors advocate complete 
 
muscular coverage to maxi-
mize vascularity 
 
and to prevent any contact of the TE 
 
with the
overlying mastectomy incision .[36,38]
For 
 
submuscular pocket creation, the patient in placed in the
supine position with 
 
the homolateral upper arm adducted at 60 ;
the pectoralis major muscle is dissected from its insertion on the
ribcage, starting with the 
 
lateral edge. The aponeurosis of the
anterior rectus and external oblique muscles are thus exposed. The
pectoralis major is then also dissected medially 
 
from its sternal
attachment, from the inferior edge of the pocket up to the second
rib . The pectoralis major can now be elevated, and the sub-[36]
pectoral pocket can be superiorly 
 
dissected in a relatively avascular
plane, following the preoperative markings. At this 
 
stage, care
should be taken not to injure the thoracoacromial vessels or 
 
the
perforator from the internal mammary 
 
artery 
 
in the medial second
intercostal space.
Complete muscular coverage of the TE is initially obtained by
raising the serratus anterior muscle completely . However, once[83]
the muscle is lifted off its insertion on the ribcage, the chest wall
remains uncovered and painful; furthermore, the suture for 
 
the
inferolateral de nition of the breast pro le may be unreliablyﬁ ﬁ
positioned at this level . The 
 
alternative is to only dissect the[73]
lower slips of 
 
the serratus anterior muscle to complete the
inferolateral portion of the submuscular pocket. Care should be
taken not to interrupt the bridging fascia between the pectoralis
major and the serratus anterior. Dissection through the intercostal
spaces should also be avoided. At this stage, the lateral edge of the
pectoralis minor muscle can be raised in 
 
continuity with the lower
slips of the serratus anterior 
 
muscle to ensure superolateral
retention of the TE and prevention of migration toward the 
 
axilla.
Conversely, a partial submuscular pocket for the TE can be 
 
ob-
tained by creating a musculofascial one. Once the pectoralis major
muscle has been raised, the serratus anterior muscle is elevated in a
plane within the muscle along with its 
 
overlying fascia . With[73]
this approach, a portion of the muscle will 
 
still cover the rib cage.
To avoid malposition or rotation of the expander, the sub-
muscular pocket should be designed to suit the selected TE. How-
ever, in all cases, the medial border should be at least 1e2 cm away
from the midline, and the lateral border should be at the anterior
axillary line.
Inferior coverage 
 
of the TE is normally achieved by elevating the
fascia of the anterior rectus muscle; however, for 
 
patients under-
going skin-reducing mastectomy, the dermal-adipose inferior apﬂ
is used for coverage of the lower pole .[36]
Traditionally, anatomically-shaped TE were placed just at the
IMF. It was widely accepted that preserving the IMF and placing an
anatomically shaped TE should be suf cient to 
 
maintain the breastﬁ
contour . As a result, the anatomical TE could eventually be[84]
replaced with an anatomical implant of the same size and contour
[85,86]. However, the TE tends 
 
to assume a round shape as its
volume increases and, given the restrictive capacity of the IMF, the
point of maximal expansion would not 
 
be at the lower pole; this
tended to result in a breast with very constricted 
 
lower quadrants.
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To address this issue, surgeons started placing a full-height TE
1e2 cm below the IMF; this approach minimized overexpansion of
the upper pole and maximized that of the lower quadrants [73].
This approach necessitated a curvilinear fasciotomy through the
inferolateral 
 
fascial layer into the subcutaneous fat, at or just below
the IMF, 
 
to allow proper lower pole expansion and avoid TE
displacement. Indeed a fascial band 
 
across the lower pole can often
prevent anterior expansion and compression of the 
 
TE. Once the
pocket has been 
 
created, it is thoroughly irrigated to remove any
cautery char or loose fat, and to highlight any bleeding points.
Various irrigant solutions have been proposed; the most popular
ones are triple antibiotic of Adams (comprising 80 mg of genta-
micin, 1 g 
 
of cefazolin, and 50,0 0 0 U of bacitracin [or equivalent
vancomycin], diluted in 50 0 mL of normal saline); single antibiotic
solution; 
 
diluted povidone iodine; and normal saline .e [87 89]e
Subclinical pocket infection has 
 
been identi ed as a possible eti-ﬁ
ology of capsular contracture, but this has not 
 
yet been conclusively
demonstrated. 
 
No comparative study on the ef cacy of differentﬁ
irrigation solutions has been carried out either .[38]
The TE is completely evacuated of any retained air and then
in ated with saline up to 20% 30% of its nal volume to facilitateﬂ e ﬁ
its insertion into the pocket. However, Hall-Findlay et al. have[38]
suggested that it be inserted 
 
in a completely de-in ated state so asﬂ
to minimize the risk of 
 
damage to tissues, and that it be 
 
unfurled by
in ation with 60 120 cc of saline only after 
 
it is in position.ﬂ e
If the pocket is 
 
of the correct size, the properly positioned 
 
TE
will have the integrated valve 
 
at its upper pole and will not be
folded on itself. Once the TE is in place, 
 
the pocket is closed with re-
absorbable interrupted sutures. One or two drains should have
been placed prior to TE placement.
Final intraoperative expansion may vary widely. Earlier, very
small amounts of uid were use to in ate the TE to avoid provokingﬂ ﬂ
mastectomy ap necrosis . However, studies have demon-ﬂ [90]
strated that intraoperative expansion with large volumes did not
result in higher rate of skin ap necrosis and that, in fact, lower TEﬂ
volumes were associated with higher risk of postoperative com-
plications such as hematoma 
 
and seroma formation [19,91].
Nowadays, TEs are lled with saline up to 50% of the nal volumeﬁ ﬁ
intraoperatively, depending on the overlying sof t tissue laxity and
appearance. Generally, 20% of the nal TE volume is usually wellﬁ
tolerated by most patients [19,36,38,73,91].
Recently, Breuing and Salzberg have 
 
used ADM for[22] [92]
complete coverage of the TE, which represents 
 
a remarkable
adjunction in the eld of alloplastic breast reconstruction. Theﬁ
ADM, which may be 
 
of fetal bovine, porcine, or human cadaver
origin, acts as a pectoralis extender, covering the inferolateral
portion of the TE and obviating the need for elevation of the ser-
ratus anterior muscle, the pectoralis minor muscle, and the rectus
abdominis fascia . The ADM is typically a 8[22,92 97e ]  
 
16 cm
sheet of dermal matrix that is sutured to the detached pectoralis
major muscle edge and functions as a sling or hammock for the TE.
Advocates of ADM point out the many advantages deriving from its
use: for example, larger pocket size; higher intraoperative ll vol-ﬁ
ume (even double) ; increased expansion and enhanced de -[38] ﬁ
nition of the lower pole, resulting in more natural shape and 
 
ptosis;
less lower pole rippling; increased control over the IMF and the
lateral mammary border; reduced postoperative pain; faster post-
operative expansion; and lower capsular contracture formation
[97e11 2 ] . However, these aesthetic advantages have mostly been
accepted on 
 
the basis of empirical or 
 
anecdotal evidence [113e115 ].
Some authors have reported increased early complication rates
(hematoma, seroma formation, and infection) with the use of ADM
[103,116]. Moreover, ADM can cost between $2100 and $3400,
depending on the size of the dermal sheet required [117]. Despite
this, Krishnan et al. [118] found ADM to be a 
 
cost-effective
therapeutic adjunct for 
 
breast reconstruction due to its better
long-term aesthetic and clinical bene ts, and reported that it isﬁ
particularly suited for patients 
 
undergoing two-stage, immediate,
TE-based breast reconstruction. In a recent review, Kim et al. [119]
reported acceptable complication rates of 8.6% 19.5% after ADMe
breast reconstruction. Finally, in view 
 
of the popularity of ADM and
the uncertainties regarding 
 
its indications and contraindications,
both Vu et al. [120] [121]and Jordan et al. have recently proposed
an algorithmic approach to aid decision-making with regard to the
use of ADM.
A polyester mesh (SurgiMesh ® PET) has been proposed as an
alternative to ADM 
 
in alloplastic breast reconstruction and has
shown promising results [122,123]. SurgiMesh ® PET is a 
 
safe syn-
thetic 
 
mesh that has been used in surgery as an alloplastic material
for over 40 years and can ensure aesthetic bene ts similar to thoseﬁ
obtained with ADM, without the drawbacks of high cost and local
policy restrictions.
A few authors have also proposed dermal autografts as an
alternative to ADM [124e126]. The autologous dermal graft can be
harvested during the time of the mastectomy as a 
 
horizontally-
oriented ellipse 
 
in the lower abdomen if a preexisting scar is pre-
sent 
 
(mainly resulting from a Pfannenstiel incision) or 
 
from the
contralateral breast if a reductive mastoplasty 
 
is planned. Lynch at
al conducted a prospective study to compare the outcomes of[126]
TE-breast reconstruction by means of dermal autografts and ADM.
They reported that the dermal 
 
autograft group had 
 
a higher
intraoperative nal TE volume, but no difference was seen in theﬁ
number 
 
of postoperative 
 
in-of ce 
 
expansions or the time to TE/ﬁ
implant exchange. Major and minor complication 
 
rates, as well as
total costs, were higher in the ADM group. Cosmetic outcome was
similar in the two groups. Histologic analysis showed that 
 
inte-
gration into the surrounding tissue was better with the autograft,
with extensive revascularization and vessel ingrowth.
5.1.2. Delayed breast reconstruction
When delayed breast reconstruction is required to allow time
for completion of chemotherapy and/or radiotherapy, the contra-
lateral breast 
 
can be used as a template to design the boundaries of
the pocket. The surgical procedure is similar to that of immediate
reconstruction. Once the preexisting scar is excised, the skin apsﬂ
are elevated till the lower margin of the pectoralis major 
 
muscle is
exposed; the muscle is then lifted in the same fashion as in im-
mediate reconstruction. Alternatively, the subpectoral space can be
approached through the muscle 
 
itself by a splitting incision
running parallel to the 
 
muscle bers. This access spares muscleﬁ
ﬁbers that will naturally close the incision when they contract.
Moreover, as the muscle bers run perpendicular to the skin inci-ﬁ
sion, the muscle will provide coverage to the TE if skin necrosis
should occur. The main drawback is that relatively more extensive
skin ap dissection is needed. During delayed reconstructionﬂ
complete lateral coverage of the TE is not mandatory; thus, the
anterior rectus fascia, serratus anterior muscle, and pectoralis mi-
nor muscle can be spared without compromising TE coverage and
the nal cosmetic outcome. Just as in immediate breast recon-ﬁ
struction, precise dissection of the pocket must be achieved by
utilizing the same anatomic landmarks, so that proper TE place-
ment is possible. A closed-bulb 
 
suction drain is usually placed over
the pectoralis 
 
muscle prior to skin closure, preventing it from being
in contact with the TE [127]. ADM can be applied too, in which case
a tunneled drain is placed inside the pocket. The nal intra-ﬁ
operative volume of the TE 
 
follows the rules of immediate setting.
5.2. Expansion
Tissue expansion is normally started from the 10th to the 14th
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postoperative day (POD) as outpatient expansion, and is usually
repeated every 1 e4 weeks according to the patient will . The TE[38]
is in ated with 60ﬂ e120 cc of saline each time, the volume being
decided by the clinical appearance of the mastectomy aps andﬂ
patient discomfort.
Early and fast tissue expansion makes the process easier,
because the more one waits the more scar is produced 
 
.[128]
Indeed, tissue expansion becomes hard at 6 8 weeks after surgerye
[73]. The desired expansion is usually achieved by 2 months.
However, second stage reconstruction takes place only after 6
months (even though exchange to nal implant is also reported at 6ﬁ
weeks after the nal expansion) in order to let the 
 
tissues relax soﬁ
that, once the TE is replaced with the de nitive implant, 
 
the breastﬁ
will 
 
have a naturally ptotic appearance [62,73,129]. For the same
reason, it is common practice to overexpand the TE to 110% 120%e
of the required volume.
5.3. Second stage
As in delayed breast reconstruction, the preexisting scar (which
usually appears widened as a consequence of tissue expansion) is
excised. Once the pectoralis major muscle is 
 
exposed, access to the
submuscular pocket is achieved either by the muscle-splitting
approach or via a layered technique. Indeed, muscle and capsule
are often not easily discernible and therefore both muscle and
capsule 
 
are incised 
 
as close as possible to the 
 
IMF by raising the
inferior mastectomy skin ap. At this point, there is no consensusﬂ 
on whether a capsulotomy or a capsulectomy 
 
is to be performed.
Nava et al. 
 
advocates complete capsulectomy followed by the[36]
rede nition of the IMF by suturing the lower edge 
 
of the super cialﬁ ﬁ
fascia to the chest wall musculature using continuous 
 
absorbable 1/
0 stitches. Hall-Findlay et 
 
al. deem complete capsulectomy[38]
unnecessary as it can lead 
 
to loss of soft 
 
tissue coverage, jeopardize
blood supply to the overlying skin, and increase in ammation. 
 
Theyﬂ
recommend a circumferential capsulotomy into the subcutaneous
fat, along with a zigzag inferior pole capsulotomy, to allow lower
pole distension and overhang. Moreover, direct capsulotomies can
be added in areas that need to expand further, while capsulor-
rhaphy by means of 2-0 silk sutures is used for correcting over-
expanded areas. When necessary, the IMF is re-established by
suturing the undersurface of the 
 
mastectomy ap to 
 
the expanderﬂ
capsule 
 
by means of absorbable braided sutures.
Cordeiro 
 
et al. also perform a circumferential capsulotomy.[73]
Indeed, radial 
 
scoring of the capsule ensures centripetal release
only, with no anterior release, and is best suited for a constricted
tuberous breast but not for the more frequent anteroposteriorly
constricted breast. Circumferential capsulotomy is performed at the
level of the tightest portion of the capsule (i.e., 1 2 cm anterior toe
the chest wall) and usually ensures a 1e7 cm anterior release.
The selected implant can then be inserted in place. A 
 
closed
suction drain is 
 
usually placed prior to wound closure with double-
layered braided absorbable sutures.
6. Postoperative care
TE-implant based reconstruction usually does not require any
special postoperative care. Prophylactic antibiotics are commonly
administered, but should be limited to the rst 24 postoperativeﬁ
hours since longer use increases the risk s of drug-resistant bacteria
and more severe infections [130]. Postoperative pain is usually not
long lasting and can be easily managed with analgesics.
A supportive brassiere should be worn for 
 
the rst postoperativeﬁ
month. Patients should avoid intense physical activity for the rstﬁ
2 3 weeks. The usual surgical wound care practices should follow.e
Drainage can be safely removed once the output is 30 mL/day.<
7. Secondary procedure
NAC reconstruction can be performed as early as the 2nd post-
operative month af ter second stage reconstruction by means of
local aps; tattooing is delayed till 6 weeks af ter NAC reconstruc-ﬂ
tion [131].
Rigotti et al. [132] were the rst to describe the effectiveness ofﬁ
autologous fat grafting (AFG) for the treatment of radio-induced
damage 
 
to 
 
soft tissue in the reconstructed breast. Serra et al.
[133] reported improved outcome in irradiated patients who have
undergone AFG plus TE-based breast reconstruction. Indeed, AFG
has been shown to thicken the subcutaneous tissue and also to
improve the 
 
texture 
 
of the irradiated skin by enhancing 
 
its vascular
supply [134].
This regenerative 
 
potential and therapeutic 
 
effect of the AFG
that go beyond simple lling capability is mainly due to the pres-ﬁ 
ence adipose-derived stem cells (ASCs) [135e140]. 
 
ASCs are an
adult population of 
 
mesenchymal stem cells 
 
that can differentiate
into multiple cell lineages and secrete 
 
paracrine factors [141e145].
Thus, angiogenesis and wound healing are strongly enhanced,
leading to higher fat-graft survival as 
 
well as dermal and subcu-
taneous 
 
tissue regeneration [146e14 8] .
In addition to being able to reduce radio-induced damage, AFG
can also correct any residual contour deformities following implant
breast reconstruction [149,150]. AFG appears to be a feasible and
effective technique for correction of the many deformities that may
occur in any 
 
breast quadrant, including medially located para-
sternal deformities, upper visible implant edges, asymmetry with
the contralateral breast, and upper outer defects underneath the
anterior axillary fold [151].
8. Complications
Complications following TE-based breast reconstruction are
divided into 
 
early (occurring by the 3rd postoperative month and/
or prior to any adjuvant therapy) and late complications [152]. Early
complications can be further divided into minor and 
 
major ones
[153]. Complications include infection, hematoma, seroma, pain,
skin ap necrosis, huge wound healing breakdown, capsularﬂ
contracture, NAC necrosis, and implant exposure/loss. Any
complication that can be managed conservatively is identi ed as 
 
aﬁ
minor complication; a major complication is usually one that calls
for secondary procedures.
Hematoma formation, seen in 0% 5.8% of patients, is usuallye
clinically recognized by the rst or second PODﬁ [154]. If drainage is
functioning properly, the bleeding can be recognized and managed
immediately. However, when clots obstruct the drainage, 
 
blood
may gather within the pocket, and revision surgery is usually
necessary. Hematoma of any size should be immediately evacuated
as it 
 
may lead to capsular contracture. Seroma can usually be
avoided with 
 
a closed suction system, but if extensive, open
drainage may be necessary.
Erythema, per se, is a normal body reaction and will eventually
resolve by itself. However, when associated with the classical signs
and symptoms of infection, intravenous antibiotics 
 
should be
administered as soon as 
 
possible. Infection rates range from 0% to
7% and if not correctly treated, the TE/implant will have to be
removed and reinserted at about 3 6 monthse [155].
Skin envelope necrosis occurs in 0% 21% of patientse [154].
Partial or complete mastectomy ap necrosis may be seen, usuallyﬂ
starting from the suture line; however, the muscles of the pocket
should be able to cover the implant. A 
 
limited area of necrosis may
be managed conservatively with topical antibiotics and local
wound care, but for wider areas curettage of the super cial layerﬁ
and advanced wound dressing are mandatory. 
 
When the area of
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skin necrosis is very large, implant removal may be the only solu-
tion; TE/implant reinsertion should not be rescheduled earlier than
3 6 months after surgery. Salvage surgery, with local advancemente
of the remaining envelope after excision of the necrotic area or
distant ap, may also be performed.ﬂ
Reported rates of necrosis of the NAC range from 
 
0% to 48%, 
 
but
is 10% in most series< [156].
Malfunction of the expander implant in 
 
the early postoperative
period is rare. Proper placement 
 
of the expander and con rmationﬁ
of port patency after skin closure during the operative procedure
should be suf cient to avoid need for any 
 
revision surgery.ﬁ
Late complications may occur at any time 
 
in the patient's life-
time, starting from the 3rd postoperative month. Delayed implant
de ations and rupture rate increase as the implants ages, with theﬂ
reported rate being 15% at 3 e10 
 
years after implantation .[36]
Diagnosis may 
 
not be easy; breast size and shape will not neces-
sarily change, and mammograms do not always detect implant
rupture. 
 
Magnetic resonance imaging, with sensitivity of 86.7% 
 
and
speci city of 88.5%, is the gold 
 
standard 
 
for detecting implantﬁ
rupture 
 
[157]. In case of documented implant rupture, exploration
and implant exchange are 
 
required.
Capsular contracture (Baker III/IV) is generally the more
frequent 
 
complication, occurring in 16% 30% of patientse [158]. The
incidence of capsular contracture increases by 1% 
 
per breast per
year [159]. Wrinkling may also occur in 20% 25% of patients.e
In 200 6, 
 
Cordeiro et al. [19] reported one of the largest series
(1522) of TE-based breast reconstruction. The overall early
complication rate 
 
(5.8%) and the complication rate af ter TE inser-
tion (8.5%) were signi cantly higher than that after TE/implantﬁ
exchange (2.7%). The most common perioperative complication
was infection (2.5%), followed by native skin ap necrosis (2.0%).ﬂ
The complication rate was higher in immediate reconstruction than
in delayed reconstruction (8.6% vs. 3.8%). Early complications
caused expander explantation in 2.7% of the reconstructions.
Basta et al. [160] performed a head-to-head meta-analysis of
outcomes, comparing conventional two-stage implantation with
direct-to-implant reconstruction. It emerged that even though both
are successful reconstructive strategies with similar infection,
seroma, hematoma, 
 
and contracture rates, the direct-to-implant
approach 
 
was associated with greater risk of 
 
ap necrosis andﬂ
implant failure.
As previously stated, TE-based breast reconstructions 
 
af ter
postmastectomy radiation 
 
therapy consistently show high rates of
acute and chronic complications, as well as poor aesthetic out-
comes [161]. Even modern 
 
radiation delivery techniques do not
lower the complication rates. Severe capsular contracture is one of
most common complications; it can occur when TE/implant ex-
change 
 
has been already performed prior to adjuvant radiation
therapy. The reported incidence in literature ranges between 16%
and 68% [27,28].
Ascherman et al. [162] conduced a retrospective study in which
they evaluated the complications and aesthetic outcomes 
 
of 104
patients who underwent TE-based reconstruction; 27 of these pa-
tients also underwent radiation therapy, either before or after
mastectomy. The 
 
overall complication rate was 40.7% for irradiated
breasts 
 
vs. 16.7% for non-irradiated breasts. Removal or replace-
ment of the implant was performed in 18.5% of the irradiated
breasts 
 
vs. 4.2% of the non-irradiated 
 
breasts. The 
 
extrusion rate
was also higher for the irradiated breasts (14.8% vs. 0%). Bene-
diktsson and Perbeck [163] conducted a similar study and reported
that the capsular contracture rate was signi cantly higher forﬁ
irradiated breasts than for non-irradiated ones (41.7% vs. 14.5%). On
the other hand, Codeiro et al. reported an implant 
 
removal/[59]
replacement rate of 11.1% and acceptable aesthetic outcomes in
most patients. Severe (Baker IV) capsular contracture occurred 
 
only
in 5.9% of 
 
irradiated reconstructed breasts in their series.
9. Outcomes
Satisfaction rates in patients undergoing TE/implant-based
breast reconstruction range from 61% to 78%; in comparison, pa-
tients undergoing autologous breast reconstruction have rates
ranging 
 
from 72% to 79% [164,165] [166]. Clough et al. noted that
satisfaction with aesthetic results shows a decline from the initial
rate of 86% at 2 years to 54% at 5 years after implant reconstruction.
This decrease is multifactorial but may be partly attributable to late
complications, such as capsular contracture and asymmetric
contralateral ptosis. Patients with bilateral prosthesis (contralateral
augmentation) usually have relatively higher satisfaction rates
(79.2%), which may be partly due to the improved shape of
the breast and better symmetry achieved with bilateral recon-
struction [167].
10. Conclusions
TE-based breast reconstruction is a safe, 
 
reliable, and ef caciousﬁ
procedure [19,91,168]. Skin- and nipple-sparing mastectomies
allow preservation of native soft-tissue of the breast and thus
enable breast contour reconstruction with little manipulation of
surrounding tissues [170,171].
Due 
 
to re nements in surgical techniques and implant tech-ﬁ
nology, improved cosmetic outcomes are being achieved. the
adjunctive use of ADM had further broadened the alloplastic
breast reconstruction indication and also enhanced aesthetic
outcomes. While AFG 
 
is an effective secondary procedure to cor-
rect any residual asymmetry with the contralateral breast or
improve the radio-induced skin damage thank s to the presence of
ASCs [169]. Appropriate pocket positioning and expander place-
ment are mandatory for a satisfactory nal result. More realisticﬁ
reconstruction, even in patients with aggressive surgical re-
sections, can now be obtained, thanks to advances in cohesive-
silicon implants. Autologous reconstruction results in a higher
satisfaction rate and should be considered the gold standard for
breast reconstruction in the setting of radiation injury. However,
many patients ask for 
 
TE/implant-based reconstruction to avoid a
donor defect, limit recovery time and potential morbidity, and to
exercise choice in the size of the reconstructed breast. Surgeons
must deal with the patient's desire 
 
and expectations and it is
important to ensure that the patient has realistic expectations so
that there is no disappointment with the nal cosmetic results.ﬁ
The reconstructive surgeon must aim for balance and symmetry
and ensure that the patient gets the 
 
best cosmetic outcome
achievable.
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